The therapeutic efficacy of “BC@Z-M + L” in tumor suppression was significantly impaired following the depletion of these T cell subsets (Supplementary Fig. 57), highlighting the essential roles of CD4/CD8 T cells in mediating the in vivo anti-tumor immune response. The gene discussed is CD8A; the disease is breast cancer.